홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Acetic Acid → N-({3-[(3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1H-indazol-1-yl)methyl]phenyl}methyl)acetamide

HRID 1892957
인쇄

반응식

HRID 1892957 반응식
N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.F[P-](F)(F)(F)(F)F.[C:25]([OH:28])(=O)[CH3:26].C(N(CC)C(C)C)(C)C.C(O)=O.[NH2:41][CH2:42][C:43]1[CH:44]=[C:45]([CH2:49][N:50]2[C:58]3[C:53](=[C:54]([OH:59])[CH:55]=[CH:56][CH:57]=3)[C:52]([NH:60][S:61]([C:64]3[S:65][C:66]([Cl:69])=[CH:67][CH:68]=3)(=[O:63])=[O:62])=[N:51]2)[CH:46]=[CH:47][CH:48]=1>CN(C=O)C>[Cl:69][C:66]1[S:65][C:64]([S:61]([NH:60][C:52]2[C:53]3[C:58](=[CH:57][CH:56]=[CH:55][C:54]=3[OH:59])[N:50]([CH2:49][C:45]3[CH:44]=[C:43]([CH2:42][NH:41][C:25](=[O:28])[CH3:26])[CH:48]=[CH:47][CH:46]=3)[N:51]=2)(=[O:62])=[O:63])=[CH:68][CH:67]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 176Acetic AcidHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 136346357n-(1-{[3-(Aminomethyl)phenyl]methyl}-4-hydroxy-1h-indazol-3-yl)-5-chloro-2-thiophenesulfonamide formate salt

생성물 1

HCID 136116031
N-({3-[(3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1H-indazol-1-yl)methyl]phenyl}methyl)acetamide

시약·촉매·용매 1

HCID 6228Dimethylformamide용매2회

실험 절차

To a solution of O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (39.7 mg, 0.064 mmol) in anhydrous DMF (1 mL) was added at room temperature acetic acid (3.36 μL, 0.059 mmol), followed by N,N-diisopropylethylamine (0.031 mL, 0.18 mmol) and finally a solution of N-(1-{[3-(aminomethyl)phenyl]methyl}-4-hydroxy-1H-indazol-3-yl)-5-chloro-2-thiophenesulfonamide formate salt (for a preparation see Intermediate 15) (29 mg, 0.059 mmol) in anhydrous DMF (1 mL) and the reaction mixture was stirred at room temperature for 30 min. The mixture was partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate. The organic layer was separated, washed with brine:water (1:1), passed through a hydrophobic frit and evaporated in-vacuo to yield a colourless oil (23 mg). This was dissolved in MeOH:DMSO (1 mL) and purified by MDAP Sunfire C18 column eluting with solvents A/B (A: 0.1% v/v solution of formic acid in water, B: 0.1% v/v solution of formic acid in acetonitrile) (25 min run). The appropriate fraction was evaporated in-vacuo to yield the title compound as a colourless oil (20 mg, 69%). LCMS (System B) RT=2.41 min, ES+ve m/z 491/493 (M+H)+.

후처리

  1. customThe mixture was partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate
  2. customThe organic layer was separated
  3. washwashed with brine:water (1:1)
  4. customevaporated in-vacuo

출처 및 근거

ORD 기록
ord-b71e32e73ad1424289bd15edc1fa433f
출처 데이터셋
uspto-grants-2013_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08507543B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트